Literature DB >> 22964725

Variation in risk-adjusted hospital readmission after treatment of appendicitis at 38 children's hospitals: an opportunity for collaborative quality improvement.

Samuel Rice-Townsend1, Matthew Hall, Jeff N Barnes, Stuart Lipsitz, Shawn J Rangel.   

Abstract

OBJECTIVES: To identify risk factors associated with readmission for children treated with appendicitis, and to characterize variation in risk-adjusted readmission rates between children's hospitals. BACKGROUND DATA: Hospital readmission has been increasingly targeted as a marker for quality of care, yet little is known regarding risk factors associated with readmission or the degree of performance variation that exists between hospitals for this cohort of patients.
METHODS: Retrospective cohort study of 47,866 patients treated at 38 children's hospitals (2006-2010). Multivariate regression was used to examine and adjust for the influence of risk factors on 30-day readmission rates. Hospitals were considered performance outliers if their readmission rate and 95% confidence interval (CI) did not include the overall rate.
RESULTS: Factors associated with readmission included disease severity [high vs. low: odds ratio (OR) 4.57, 95% CI: 3.72-5.60; moderate vs. low: OR 2.29, 95% CI: 2.00-2.61] and insurance status (public vs. private: OR 1.14, 95% CI: 1.0-1.29). After adjustment for these factors, the relative decile-based performance rankings changed for 17 (45%) of the 38 hospitals and six (16%) hospitals changed the outlier status based on their standardized readmission rates. A 3.8-fold variation in standardized readmission rates was found across the 38 hospitals after adjustment (overall rate: 8.9%, range: 4.1%-15.4%, P < 0.0001), and 24 (63%) hospitals were identified as outliers (12 low performers and 12 high performers).
CONCLUSION: Significant variation in risk-adjusted readmission rates exists among children's hospitals after treatment of appendicitis, and outliers can be identified at both ends of the performance spectrum. These findings may have important implications for the identification and dissemination of "best practices" from exemplar hospitals.

Entities:  

Mesh:

Year:  2013        PMID: 22964725     DOI: 10.1097/SLA.0b013e318268a663

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  7 in total

1.  Pediatric surgery readmissions: a root cause analysis.

Authors:  S Burjonrappa; A Theodorus; A Shah; I T Cohen
Journal:  Pediatr Surg Int       Date:  2015-04-16       Impact factor: 1.827

2.  Importance of Compliance Audits for a Pediatric Complicated Appendicitis Clinical Practice Guideline.

Authors:  Mehul V Raval; Alan B Kwan; Curtis D Travers; Kurt F Heiss
Journal:  J Med Syst       Date:  2018-11-07       Impact factor: 4.460

3.  Pediatric readmission classification using stacked regularized logistic regression models.

Authors:  Gregor Stiglic; Fei Wang; Adam Davey; Zoran Obradovic
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

4.  Pediatric readmission prevalence and variability across hospitals.

Authors:  Jay G Berry; Sara L Toomey; Alan M Zaslavsky; Ashish K Jha; Mari M Nakamura; David J Klein; Jeremy Y Feng; Shanna Shulman; Vincent W Chiang; Vincent K Chiang; William Kaplan; Matt Hall; Mark A Schuster
Journal:  JAMA       Date:  2013-01-23       Impact factor: 56.272

5.  Morbidity of peripherally inserted central catheters in pediatric complicated appendicitis.

Authors:  Jason P Sulkowski; Lindsey Asti; Jennifer N Cooper; Brian D Kenney; Mehul V Raval; Shawn J Rangel; Katherine J Deans; Peter C Minneci
Journal:  J Surg Res       Date:  2014-03-13       Impact factor: 2.192

6.  Lack of improvement: a national assessment of readmission rates after pediatric bladder reconstruction.

Authors:  Seth Cohen; Kerrin Palazzi; Sarah Marietti; George Kaplan; George Chiang
Journal:  Nephrourol Mon       Date:  2014-09-05

7.  Weekend Admissions Associated with Increased Length of Stay for Children Undergoing Cholecystectomy.

Authors:  Danny Lascano; Rachel Lai; Gustavo Stringel; F Dylan Stewart
Journal:  JSLS       Date:  2021 Oct-Dec       Impact factor: 2.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.